RECRUITING

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This research study is looking into the effects of clavulanic on smoking behavior in adult cigarette smokers. The primary study hypothesis is that, compared to placebo, clavulanic acid will reduce smoking over the course of the study.

Official Title

An fMRI Study of the Effects of Clavulanic Acid on Drug Addiction

Quick Facts

Study Start:2019-03-26
Study Completion:2024-12-31
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT03713424

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 65 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. Pregnancy or breastfeeding
  2. Severe psychiatric disorders
  3. Active substance abuse
  4. Unstable medical conditions
  5. Inability to comply with study requirements

Contacts and Locations

Study Contact

Madhura Athreya, MS
CONTACT
573-882-2977
athreyam@health.missouri.edu
Brett E Froeliger, PhD
CONTACT
573-882-4785
froeligerb@health.missouri.edu

Principal Investigator

Brett Froeliger, PhD
PRINCIPAL_INVESTIGATOR
University of Missouri-Columbia

Study Locations (Sites)

University of Missouri - Columbia
Columbia, Missouri, 65211
United States

Collaborators and Investigators

Sponsor: University of Missouri-Columbia

  • Brett Froeliger, PhD, PRINCIPAL_INVESTIGATOR, University of Missouri-Columbia

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2019-03-26
Study Completion Date2024-12-31

Study Record Updates

Study Start Date2019-03-26
Study Completion Date2024-12-31

Terms related to this study

Additional Relevant MeSH Terms

  • Tobacco Use Disorder